You are here: Home » Markets » News
Business Standard

Cipla gains on expansion plan in Europe

Cipla gained 3% after the company agreed to market paediatric vaccines made by Serum Institute of India in Europe

SI Reporter  |  Mumbai 

Shares of Cipla are trading higher by 3% to Rs 616 on the BSE after the company agreed to market paediatric vaccines made by Serum Institute of India in Europe, in a move that marks India's fourth-largest drugmaker's entry into the vaccines space.

Financial details of the deal with Serum Institute, one of India's largest makers of vaccines, were not disclosed.

Cipla, which exports to over 170 countries, is working on expanding its presence in Europe, a region that contributed 5.7% to the company's total revenue in the year to March 2013.

As part of this strategy, Cipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.

"We see vaccines as one of the critical components of our offering to European patients," Cipla's Europe business head Frank Pieters said in a statement.

The stock opened at Rs 607, touched a high of Rs 617 and a low of Rs 596 on the BSE. A total of 143,384 shares have changed hands on the BSE so far.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, November 20 2014. 12:54 IST
RECOMMENDED FOR YOU
.